Phagocytosis and intracellular killing by polymorphonuclear cells from patients with rheumatoid arthritis and Felty's syndrome. 1985

F C Breedveld, and M T van den Barselaar, and P C Leigh, and A Cats, and R van Furth

The present in vitro study concerned the phagocytosis and intracellular killing by polymorphonuclear cells (PMN) of 5 patients with rheumatoid arthritis (RA) and 12 patients with Felty's syndrome (FS). PMN phagocytosis was assessed by microbiologic and morphologic methods, and intracellular killing was measured independently of continuous phagocytosis of viable bacteria (Staphylococcus aureus). PMN from patients with RA or FS ingested S aureus opsonized with immunoglobulins and complement as effectively as did PMN from healthy donors. However, the capacity of patient PMN to ingest S aureus opsonized with sera lacking complement activity, e.g., heat-inactivated donor serum and the sera of 2 patients with FS, was lower than that of healthy donor PMN. This decreased ingestion is associated with diminished expression of Fc receptors on the membrane of PMN from patients who have RA or FS. As with sera lacking complement activity, decreased capacity to ingest S aureus was observed after preloading donor PMN with immune aggregates, which also decreased the expression of Fc receptors. PMN from patients with RA or FS were found to be as active in killing S aureus as cells from healthy donors.

UI MeSH Term Description Entries
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D011961 Receptors, Fc Molecules found on the surface of some, but not all, B-lymphocytes, T-lymphocytes, and macrophages, which recognize and combine with the Fc (crystallizable) portion of immunoglobulin molecules. Fc Receptors,Fc Receptor,Receptor, Fc
D001770 Blood Bactericidal Activity The natural bactericidal property of BLOOD due to normally occurring antibacterial substances such as beta lysin, leukin, etc. This activity needs to be distinguished from the bactericidal activity contained in a patient's serum as a result of antimicrobial therapy, which is measured by a SERUM BACTERICIDAL TEST. Activities, Blood Bactericidal,Activity, Blood Bactericidal,Bactericidal Activities, Blood,Bactericidal Activity, Blood,Blood Bactericidal Activities
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D005258 Felty Syndrome A rare complication of rheumatoid arthritis with autoimmune NEUTROPENIA; and SPLENOMEGALY. Felty's Syndrome,Familial Felty Syndrome,Familial Felty's Syndrome,Rheumatoid Arthritis, Splenomegaly and Neutropenia,Familial Feltys Syndrome,Felty Syndrome, Familial,Felty's Syndrome, Familial,Feltys Syndrome,Syndrome, Familial Felty,Syndrome, Familial Felty's,Syndrome, Felty,Syndrome, Felty's
D005260 Female Females

Related Publications

F C Breedveld, and M T van den Barselaar, and P C Leigh, and A Cats, and R van Furth
August 1984, British journal of rheumatology,
F C Breedveld, and M T van den Barselaar, and P C Leigh, and A Cats, and R van Furth
June 1977, Clinical and experimental immunology,
F C Breedveld, and M T van den Barselaar, and P C Leigh, and A Cats, and R van Furth
February 1984, Acta pathologica, microbiologica, et immunologica Scandinavica. Section C, Immunology,
F C Breedveld, and M T van den Barselaar, and P C Leigh, and A Cats, and R van Furth
August 1981, Annals of the rheumatic diseases,
F C Breedveld, and M T van den Barselaar, and P C Leigh, and A Cats, and R van Furth
August 1976, The Journal of laboratory and clinical medicine,
F C Breedveld, and M T van den Barselaar, and P C Leigh, and A Cats, and R van Furth
January 1970, British medical journal,
F C Breedveld, and M T van den Barselaar, and P C Leigh, and A Cats, and R van Furth
March 1984, Clinical and experimental immunology,
F C Breedveld, and M T van den Barselaar, and P C Leigh, and A Cats, and R van Furth
September 1984, Clinical and experimental immunology,
F C Breedveld, and M T van den Barselaar, and P C Leigh, and A Cats, and R van Furth
January 2012, Methods in molecular biology (Clifton, N.J.),
F C Breedveld, and M T van den Barselaar, and P C Leigh, and A Cats, and R van Furth
May 2013, Clinical rheumatology,
Copied contents to your clipboard!